Advent Pharma Ltd. (DSE:ADVENT)
15.20
+0.10 (0.66%)
At close: Oct 13, 2025
Advent Pharma Market Cap
Advent Pharma has a market cap or net worth of 1.42 billion as of October 13, 2025. Its market cap has decreased by -35.59% in one year.
Market Cap
1.42B
Enterprise Value
1.49B
Revenue
478.96M
Ranking
n/a
PE Ratio
29.08
Stock Price
15.20
Market Cap Chart
Since April 12, 2018, Advent Pharma's market cap has decreased from 3.32B to 1.42B, a decrease of -57.36%. That is a compound annual growth rate of -10.73%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 12, 2025 | 1.41B | -9.58% |
Dec 30, 2024 | 1.56B | -32.93% |
Dec 28, 2023 | 2.32B | -1.97% |
Dec 29, 2022 | 2.37B | -0.74% |
Dec 30, 2021 | 2.38B | 14.47% |
Dec 30, 2020 | 2.08B | 11.96% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
Apr 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Grameenphone | 396.31B |
Square Pharmaceuticals PLC. | 188.19B |
Robi Axiata PLC. | 152.95B |
Walton Hi-Tech Industries | 145.08B |
British American Tobacco Bangladesh Company | 140.24B |
BRAC Bank PLC. | 137.37B |
Bangladesh Export Import Company | 103.85B |
Marico Bangladesh | 87.14B |